Candidiasis : predisposing factors, prevention, diagnosis and alternative treatment by Martins, Natália et al.
Candidiasis: Predisposing Factors, Prevention, Diagnosis
and Alternative Treatment
Nata´lia Martins • Isabel C. F. R. Ferreira •
Lillian Barros • So´nia Silva • Mariana Henriques
Received: 3 January 2014 / Accepted: 18 April 2014 / Published online: 1 May 2014
 Springer Science+Business Media Dordrecht 2014
Abstract Candidiasis is the most common opportu-
nistic yeast infection. Candida species and other
microorganisms are involved in this complicated
fungal infection, but Candida albicans continues to
be the most prevalent. In the past two decades, it has
been observed an abnormal overgrowth in the gastro-
intestinal, urinary and respiratory tracts, not only in
immunocompromised patients, but also related to
nosocomial infections and even in healthy individuals.
There is a widely variety of causal factors that
contribute to yeast infection which means that candi-
diasis is a good example of a multifactorial syndrome.
Due to rapid increase in the incidence in these
infections, this is the subject of numerous studies.
Recently, the focus of attention is the treatment and,
above all, the prevention of those complications. The
diagnosis of candidiasis could become quite compli-
cated. Prevention is the most effective ‘‘treatment,’’
much more than eradication of the yeast with anti-
fungal agents. There are several aspects to consider in
the daily routine that can provide a strength protection.
However, a therapeutic approach is necessary when the
infection is established, and therefore, other alterna-
tives should be explored. This review provides an
overview on predisposition factors, prevention and
diagnosis of candidiasis, highlighting alternative
approaches for candidiasis treatment.
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Introduction
Candida species are involved in the main opportunis-
tic yeast infection in the world, candidiasis, but among
the species of the genus, Candida albicans continues
to be the most common. Although this yeast is
responsible for approximately 50–90 % of human
candidiasis, C. albicans is part of the commensal flora
of more than half of the healthy population. Coloni-
zation by this yeast is beneficial to the host, because
not only limits the growth of other opportunistic
pathogenic fungi, but also promotes the functioning of
the immune system [1–5].
In the last two decades, it has been observed a
considerable increase in the incidence of deep fungal
infections, not only in immunocompromised patients,
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but also related to nosocomial infections, and even in
healthy population [4, 6–15]. Thus, with the increased
incidence of deep fungal infections (chronic candidi-
asis), the primitive idea that they were related to a
restrict number of pathogenic fungi and specific
geographical area was completely changed. Further-
more, with the rapid increase in candidiasis incidence,
other Candida species and microorganisms besides C.
albicans have been involved in such infections [2, 5, 6,
16–18]. The balance between C. albicans and non-
Candida albicans Candida (NCAC) species deter-
mines the profiles associated with virulence. So, the
most common species are C. albicans, C. tropicalis, C.
glabrata, C. dubliniensis, C. parapsilosis, C. orthopsi-
losis, C. metapsilosis, C. krusei, C. famata, C.
guilliermondii and C. lusitaniae. Other relevant fact
associated with virulence is their capacity to form
biofilms with other species, which together with the
presence of teleomorph forms (sexual phase of fungi
in which the same biologic entity could have two
different scientific names), difficult the treatment and
alter the susceptibility profiles to traditional antifungal
agents [3, 9, 10, 13, 19–22].
Although biofilm formation lead to an increase in
the persistence and resistance to antifungals, other
factors, such as adaptation to the pH level, adherence
of yeast cells to the host cells, proteolytic enzymes,
phenotypic switching and morphological transition
(ability of yeast to change morphologically from
blastoconidia to pseudohyphae and hyphae), affect the
strategies to prevent and treat this pathogenic infec-
tion. Despite C. albicans is still the focus of a wide
range of studies, some researches have been demon-
strated a significant increasing of infections caused by
NCAC species. There are some associated factors with
the virulence. The presence of hemolytic exoenzymes
is very important because it allows an acquisition of
iron ions from hemoglobin, by yeasts. Moreover, there
is a positive correlation between this metal and the
establishment and dissemination of infections. The
metabolic activity and the capacity of biofilm forma-
tion also appear like important correlating factors of
pathogenicity, once they interfere in the level of
virulence expression and in the level of resistance to
antifungal agents. A high metabolic activity of NCAC
species was demonstrated, which could be a cause of
the increasing frequency of fungal infections related to
these yeasts, including the possibility of systemic
infections. According to these facts, it was possible to
demonstrate the complexity of the epidemiological
chain of colonization—infection processes. Like expres-
sion of virulence-associated factors is strain dependent,
an accurate identification of yeasts and their virulence-
associated factors is essential to detect the emergence of
yeasts and to predict the antifungal agents response,
considering the increasing tolerance and antifungal
resistance mechanisms [1, 2, 20, 22–24].
Due to the increasing evidence of antimicrobials
and antifungals resistance, several studies have been
developed toward the identification and evaluation of
efficient alternative therapeutics. Natural products, in
particular, those from plants, have been explored with
that purpose; the therapeutic potential of phytochemi-
cals, the synergistic effects among them and the
related mechanisms of action have been extensively
studied [25–35]. Nevertheless, many extracts/com-
pounds from plant origin remain unknown and could
constitute an alternative or complementary treatment
for candidiasis.
Considering all the stated candidiasis is indeed
much more than C. albicans overgrowth, and there-
fore, the most relevant topics involved in this fungal
infection are presented and discussed in the present
manuscript, namely description of candidiasis and
their main classes, predisposing factors, diagnosis
(signals, symptoms and methods), prevention and
alternative treatment (diet and nutrition, enhancing
immunity system, detoxification, natural antiyeast
agents and therapeutical approach) (Fig. 1).
Description of Candidiasis and Main Classes
Yeasts are part of the commensal fungi flora of the
healthy population. However, with the significant and
rapid increase in the incidence of opportunistic fungal
infections, the focus of attention has been the
treatment and, above all, prevention of those compli-
cations. Although other fungi species are involved in
nosocomial infections, such as Aspergillus spp.,
Zygomyces spp., Fusarium spp., Scedosporium spp.,
Cryptococcus spp., Trichosporon spp., Geotrichum
spp. and Rhodotorula spp., C. albicans continues to be
the most prevalent, counting to 50–90 % of the
isolates from fungal infections [1, 9, 10, 22, 36, 37].
Candida albicans is a common species in genito-
urinary and gastrointestinal tracts of healthy people,
but it is also able to cause problems, mainly vaginal
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infections in woman. This microorganism is respon-
sible for mouth and mucocutaneous infections. How-
ever, it has been frequently observed an evolution to
chronic forms, generating complicated infections,
such as septicemia, endocarditis, meningitis and
peritonitis, especially in patients with reduced immune
function or taking antibiotic therapies. Some reports
described that oral candidiasis appeared as early as the
second century A.D. by Galen, who described it as
aphthas albus. Other reviews reported that it was not
until the mid-nineteenth century that clinical nature of
oral candidiasis was defined and the etiologic agent
identified. Notwithstanding, and despite the other
types of mucocutaneous candidiasis, oral candidiasis
is still the most frequent. There has been a wide variety
of synonyms used for the members of genus Candida,
166 synonyms being recognized for C. albicans
worldwide. Actually, there are between 150 and 200
species recognized in the genus, but only seven
Candida species are classified as having major med-
ical importance, being C. albicans the most important
one. Other Candida species such as C. tropicalis, C.
glabrata, C. parapsilosis, C. stellatoidea, C. krusei
and C. kyfer are encountered in human infections [2, 5,
15, 38, 39].
The increase in the number of organ transplanta-
tions, the rise of immunocompromised individuals and
the use of invasive devices (catheters, artificial joints
and valves) are a major factor that contributes to
higher patient’s susceptibility to nosocomial infec-
tions. Despite being Candida species the fourth
leading cause of hematogenous infections, these
species are not exclusively related to nosocomial
infections (candidemia), because the same infections
can also occur in healthy population. There are several
classes of candidiasis, which have become more
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common in recent years [4, 6, 13, 17, 40, 41].
Depending on body location, the mucocutaneous
candidiasis can be classified as genital candidiasis,
intrauterine candidiasis, anal candidiasis, nails candi-
diasis and oral candidiasis (Fig. 1).
Genital Candidiasis
Vulvovaginal candidiasis (VVC) is the most frequent
type of genital yeast infection. Approximately 75 % of
women experience, at least once in their lifetime, an
episode of VVC, 40–50 % experience at least one
additional episode of infection, 20–50 % remain
without any clinical manifestation and lastly, 5 %
experience recurrent VVC episodes [9, 10, 42, 43].
Although, not being a threat to life, it is unpleasant and
problematic, causing a variable degree of itching and
whitish discharge, abundant and flocculent. This
infection is very common in pregnant women, espe-
cially in the last trimester of pregnancy, when a
variation in progesterone, estradiol and glycogen,
associated with an increase in vaginal pH, favors the
emergence of these infections. In this case, special
attention should be given due to the potential occur-
rence of contamination of the fetus in the uterus, or
even the child during childbirth. On the other hand, it
has been observed that, in individuals with diabetes,
the incidence of vaginal candidiasis is higher. Simi-
larly, patients submitted to broad spectrum of antibi-
otic therapy, used to treat bacterial infections, and
even the use of oral contraceptives, are also important
factors associated with higher rates of incidence of
VVC [42, 44–47].
In men, balanitis, which usually appear after sexual
contact, is characterized by the appearance of a rash,
more or less prickly, followed by small pustules on
rocking groove-preputial discharge, more or less
abundant. Although this kind of injury is well defined,
in particular cases it can extend to the groin and
perianal region. The major factors associated with this
type of infections are antibiotic therapies, diabetes and
vaginal secretions of the sexual partner [1, 17, 48].
Intrauterine Candidiasis
This type of infection is frequent during pregnancy. It
is important to avoid the occurrence of this type of
intense vaginitis in the last few weeks of pregnancy,
because it can complicate and extend to the uterus,
infecting the child before birth. At childbirth, or in the
first hours of life, it can be observed a widespread rash,
maculopapular or pustular–vesicular. During the fol-
lowing weeks after birth, the clinical status may be
complicated, extending to other body locations, which
usually are treated with local antibiotics [5, 42, 43, 49].
Anal Candidiasis
This type of infection is characterized by intense
itching/pruritus, accompanied by burning sensation,
and localized erythema around the anus. Skin may
appear macerated with circumscribed lesions, which
may eventually invade the intergluteal groove [49–51].
This type of infection is most common in children,
despite the frequency in women due to the use of
hormonal contraceptives, intimate hygiene products,
clothing and their practice of oral and anal intercourse,
functioning as transient colonization of local organisms
shed from the intestinal tract. As candidiasis can be
sexually acquired, males can be affected, because they
may acquire infection from the gastrointestinal tract of
their partners. However, in some cases, the factors
causing that condition are still unknown, but seems that
the main problem of this pathogenesis are secondary
infections caused by aerobic and facultative anaerobes
microorganisms, such as Staphylococcus spp., Strepto-
coccus spp. and Escherichia coli [48, 50–52].
Nails Candidiasis
Candida species are not considered normal yeasts on
nails flora. Therefore, this type of infection is a sign of
colonization (secondary growth) despite primary
infections of nail fold and nail bed with Candida
species may also occur, which are related to a disease
of the nails. Onychodystrophy or periungual tissue is
related to nail disease. This type of infection may
appear, such as paronychia and onychia. The paro-
nychia is characterized by an inflammation, more or
less painful, in peripheral skin nail, which appears red
and brilliant. The predisposing factors are essentially,
sex, different traumas (e.g., in manicure), professional
activity and hormonal variations. Although infrequent
in males, this infection can appear in cooks, confec-
tioners and employees of canning factories [1, 17, 49].
Usually, the nail injury itself, or onyxis (ingrown
nail), is secondary to paronychia. It is characterized by
a progressive striation, dyschromias (discoloration)
226 Mycopathologia (2014) 177:223–240
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and opacity of the nail plate, which ultimately
becomes crumbly. This infection appears abruptly
and painfully, leading to detachment of the nail and
can spread to other nails. Still, it can be observed
fungal colonization in interdigital areas, by Candida
species, commonly known as digital intertriginous.
Preferentially, it is located in the hands and between
the ring and middle fingers, although it can also appear
in the corners of the fingers. It is commonly associated
with professions or occupations in which there is a
frequent contact with water. The injury erythema–
scaly, itchy and exudative generally is well delimited
peripherally, and the epidermis appears detached. It is
less frequent in feet, but can reach one or more
commissures of fingers [1, 17, 49, 50].
Intertriginous can still be located at the level of the
submammary, mainly in obese women, suprapubic
fold, groin and intergluteal cleft. It is characterized by
the appearance of small vesicles and pustules, which,
by breakage, give rise to exudative red spots [1].
Oral Candidiasis
Oral and perioral candidiasis is the more common type
of acute mucocutaneous candidiasis. It is characterized
by the appearance of small spots or whitish papules on
the tongue, inside the cheeks and in the palate, forming
a creamy and very adherent layer mucosa. In some
cases, it may extend up and cover the tongue, palate and
pharynx, but also corners of the mouth could be
reached. When this happens, it is labeled as angular
cheilitis, being evidently a mucosal thickening and
cracking. This type of candidiasis particularly affects
people with immune system disorders and people with
dental prostheses. It can be also found in patients
receiving chemotherapy for cancer treatment, or taking
immunosuppressive drugs to protect transplanted
organs or in patients infected by HIV. In children and
young people, it may be involved with oral (‘‘thrush’’)
and lingual disease. In addition, and despite being very
rare, esophageal candidiasis can occur in patients
infected by HIV and cancer [2, 5, 40, 53–55].
Predisposing Factors
Although Candida species is commensal to human
organism and virtually present in healthy people, in
the past two decades, an abnormal overgrowth in the
gastrointestinal (GI), urinary and respiratory tracts has
been observed [2, 3, 6, 10, 56]. During some days after
childbirth, that species colonize the mucosa of GI tract
(40–50 %) and upper respiratory passages, as well as
the mouth, pharynx and larynx. Normally, C. albicans
lives smoothly in the inner warm creases and crevices of
the GI tract (and vaginal tract in women). During
pregnancy, Candida species colonization increases
30–40 %, depending upon altered immune response,
bacterial flora, positive variations in glycogen and pH
levels; however, mostly during the normal life cycle,
other factors can affect, such as hygiene and oral
contraceptive use, which contributes to 5–30 % of the
infections. In men, up to 10 % of these species are
found on the genitalia, in the transitional zone, between
the mucous membrane and the skin [1, 13, 18, 40, 44,
46]. The overgrowth of C. albicans is an important
cause of a wide variety of symptoms that affect directly
the well-being of individuals, and therefore, there is an
urgent need to recognize candidiasis as a complex
medical syndrome and evaluate the magnitude of the
problem regarding prevention, which passes through
the control of risk factors.
There are several factors that contribute to yeast
infection, which means that candidiasis, and more
especially chronic candidiasis, is a good example of a
multifactorial syndrome. In the next steps, the major and
most important factors are explained, namely decreased
digestive secretions, dietary factors, nutrients defi-
ciency, impaired immune system and underlying dis-
ease states, impaired liver function, drugs and prolonged
use of antibiotics and altered bowel flora (Fig. 1).
Decreased Digestive Secretions
In a normal organism, the digestive secretions, such as
hydrochloric acid, bile and pancreatic enzymes, have
an important role not only for a correct digestion, but
also to prevent Candida overgrowth and its penetra-
tion into absorptive surfaces in the GI tract. Therefore,
an improvement in digestive secretions is pivotal and,
in some cases, is an important step to treat chronic
candidiasis.
Pancreatic enzymes perform an important role as
therapeutic agents enabling an efficient and complete
digestion of proteins and other dietary compounds.
Any dysfunction on this process leads to several
problems, such as food allergies and formation of
toxic substances. Furthermore, those enzymes are
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responsible for the preservation of the integrity of
small intestine without parasites and other opportun-
ist microorganisms (bacteria, yeasts, worms and
protozoa), helping in the degradation of immuno-
complexes [57, 58].
The intake of antacids and antiulcer drugs has a
high risk of GI infections, showing a Candida species
overgrowth in the stomach. Therefore, to restore the
normal digestive secretions to proper levels, through
the use of supplementary hydrochloric acid, pancreatic
enzymes and substances that promote the normal bile
flow is highly important in the treatment of chronic
candidiasis [57, 58].
Dietary Factors and Nutrients Deficiency
A balanced organism needs all the macro- and micro-
nutrients in right proportions, and therefore, any unbal-
anced diet affects the well-being of the body and
potentiates growing and colonization of certain invad-
ers. Some foods, such as refined sugars, sucrose, fruit
juice, honey and maple syrup, have an important
interference, functioning like growth enhancers. More-
over, foods with high content of yeast and fungi favor the
growth of Candida; some examples are cheeses, alco-
holic beverages and dried fruits. Another food group that
stimulates growth is milk and dairy products, not only
because of the high content of lactose but also, in some
cases, due to the presence of antibiotics. Another
important situation observed in most individuals with
chronic candidiasis is the presence of food allergies, and
therefore, all known allergens should be eliminated [40,
42, 55, 57, 59–61]. Thus, dietary factors should be
monitored according to the needs of each individual.
Some essential nutrients usually in deficit on
chronic candidiasis are zinc, magnesium, selenium,
essential fatty acids, folic acid and vitamins B6 and A
[57, 59, 60, 62]. Furthermore, iron has been considered
as an essential micronutrient rather than a supplement,
and there are several recent studies that indicate its
important role in fostering and colonization by
microorganisms, including Candida and other yeasts
[9, 42, 63–66].
Impaired Immune System and Underlying Disease
States
Dysfunctions of the immune system turn the human
body more vulnerable to various kinds of infections.
Thus, it is of extreme importance to maintain the good
conditions of the immune system in order to prevent
overgrowth of certain microorganisms and opportunis-
tic infections. By itself, a weak immune system is
already sufficient to constrain the health and resistance
of individuals, although with the current and prolonged/
frequent consumption of antibiotics, chemotherapy,
steroids, radiation, stress, as well as some environmental
contaminants, the body is still more susceptible.
Furthermore, any disease that, directly or indirectly,
affects the immune system increases the body’s suscep-
tibility to the growth and development of pathogenic and
opportunistic microorganisms. This is the case of some
increasing prevalence diseases, such as cancer, diabetes
and hypothyroidism, that in addition to debilitate
immune system of individuals has led to a continuous
and exacerbated prescription of immunosuppressant
drugs [1, 11, 17, 18, 24, 37, 40, 41, 67–69].
In fact, the most common diseases that predispose to
an increased sensitivity to C. albicans overgrowth are
diabetes mellitus, cancer, leukemia, AIDS, thyroid
dysfunction and other diseases, in which host defense
mechanisms are suppressed or adrenal cortex steroids/
antibiotics/other similar drugs are used (immunosup-
pressed patients) [6, 10, 12, 24, 25, 37, 40, 53, 56, 70–72].
Impaired Liver Function
The modifications of the liver functions, as a result of
injury or chemical causes, can change detoxification
mechanisms. In this situation, as the liver is not able to
perform its functions properly, toxins are absorbed by
the intestine being accumulated, which affects more
the liver and other organs function, and increase the
body’s sensitivity to chemicals. The accumulation of
toxins in the body, as a result of liver damage,
associated with changes in the mechanisms of detox-
ification, also stimulates C. albicans overgrowth. One
way to diagnose if liver function is affected or if the
mechanism of filtration of the blood is not properly
being done is through the manifestation of symptoms
(e.g., psoriasis, premenstrual syndrome, among oth-
ers) of chronic candidiasis outside of digestive tract
[57, 60, 73, 74].
Drugs and Prolonged Use of Antibiotics
Antibiotics have been identified as a major responsible
factor for the development of chronic candidiasis.
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Since its mode of action is based on the elimination of
intestinal bacteria, responsible for preventing the
growth of yeasts and other pathogenic organisms, as
well as suppressing the immune system, antibiotics
action result in a C. albicans overgrowth. This
situation becomes shortly a vicious cycle: A person
with an alteration of the immune system is more
susceptible to infections, and consequently, more
infections will appear—increasing the doses and
frequency in the consumption of antibiotics. This fact
not only favors the overgrowth of C. albicans and
other yeasts, but particularly bacteria, which increas-
ingly develop mechanisms of resistance against anti-
biotics [6, 17, 42, 57, 69].
An established fact is that the indiscriminate use
of antibiotics substantially increases the risk of
developing complications caused by C. albicans and
other resistant pathogens. This is particularly impor-
tant in hospitals because nosocomial infections by
resistant microorganisms often lead to lethal com-
plications. Therefore, the reduction in the prescrip-
tion and use of antibiotics can be considered an
effective alternative to control and/or minimize the
resistance problem. Another alarming factor is the
widespread use of antibiotics in animals, which not
only contribute to microbial resistance in animals
themselves, but also indirectly affect humans: anti-
biotic resistance and consumption of food contam-
inated by antibiotics [1, 6, 17, 23, 40, 42, 43, 46, 70,
75, 76]. The increasing incidence of Crohn’s disease
and other inflammatory bowel diseases, which
previously were only prevalent in populations with
a strong genetic component, is also an important
factor [77–86].
Other drugs that could favor C. albicans over-
growth are corticosteroids, oral contraceptives and
antiulcer drugs. It should be emphasized that individ-
uals who take antiulcer drugs, such as ranitidine and
cimetidine, may develop C. albicans in the stomach
[6, 7, 40, 42, 43, 46].
Altered Bowel Flora
As described, drugs and other chemical compounds
greatly affect the well-being of the body. If the liver
does not work properly, products and metabolites
resulting from poor digestion are accumulated in the
body causing toxicity and, at the same time, favoring
pathogenic strains, and also C. albicans overgrowth.
Therefore, intestinal flora is of utmost importance in
maintaining proper intestinal health and balance,
being involved in the maintenance of nutritional
status, immune system function, cholesterol metab-
olism, carcinogenic agents and aging. It is imperative
to promote healthy and growth of beneficial intestinal
flora, not only after taking antibiotics, but also in
other situations. It should also be noted that chronic
stress greatly affects the balance of intestinal flora
and suppresses the immune system function. In other
hand, especially in women, the hormonal balance is
very important and the oral routine of contraceptive
use is itself a predisposing factor to C. albicans
overgrowth once it is a causative agent of variation in
the balance of the intestinal microflora [1, 6, 9, 23,
40, 42, 46, 87, 88].
Diagnosis
In some cases, the diagnosis of candidiasis becomes
quite complicated and difficult to establish, since the
patients present different signals and symptoms
according to age, gender, host resistance and exposure
to environmental factors. Nevertheless, some tools
could be used to screen and determine the presence of
yeast infections (diagnosis), namely questionnaire,
comprehensive digestive stool analysis (CDSA) and
laboratorial techniques (Fig. 1).
Signals and Symptoms
Despite fungi and other microbials being widespread
in the environment, the systemic infections thrive
very slowly. Most of the times, the individual
infected does not have symptoms or visible signals.
According to some authors, namely oral candidiasis
is classified considering the following aspects: dura-
tion (acute or chronic), clinical features, like color
(erythematous/atrophic), location (median rhomboid
glossitis, denture stomatitis, multifocal candidiasis
and angular cheilitis), presence of skin lesions, as
well as oral lesions (mucocutaneous) and association
with an immunocompromised host (HIV associated).
Other clinical aspects included hyperplastic or
hypertrophic appearance, characterized by papillary
hyperplasia of the palate, candida leukoplakia and
hyperplastic median rhomboid glossitis [1, 5, 17, 48,
49, 57, 59, 60].
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In a more developed stage of infection, a simple
sensation of flu or constipation could occur, such as
cough or fever, chest pain, chills, weight loss or
breathing difficulties. However, the type and the
intensity of signals and symptoms depend on the type
and location of the infection. One of the major
explanations for yeasts overgrowth is that the immune
system mechanisms are depleted, or the normal lining
of the intestinal tract is damaged. When this happens,
the body can absorb yeast cells, particles of yeast cells,
a wide of toxins and other substances, resulting in the
development of yeast syndrome [5, 49, 62].
The major symptoms of patients with yeast infec-
tion are divided in different categories, which are
described below. General symptoms include chronic
fatigue, loss of energy, general malaise and decreased
libido. Other category includes gastrointestinal symp-
toms, such as thrush, bloating, gas, intestinal cramps,
rectal itching and altered bowel function. In genito-
urinary system, the major complaints are vaginal yeast
infection and frequent bladder infections. Depression,
irritability and inability to concentrate are the general
complaints of nervous system. The occurrence of
allergies, chemical sensitivities and low immune
function are also very frequent. A great majority of
patients has shown, in the past history, one or more of
these conditions: chronic vaginal yeast infections;
chronic antibiotic use for infections or acne; oral birth
control and oral steroid hormone usage, as well as
premenstrual syndrome; sensibility to foods, chemi-
cals and other allergens; endocrine disturbances;
eczema; psoriasis; and irritable bowel syndrome.
One of the most important aspects is that most patients
have craving for foods rich in carbohydrates or yeast
[1, 5, 49, 62].
Occasionally, patients saying that ‘‘feel sick all
over’’ characterize the syndrome. It is important to
consider that women patients have eight times more
yeast infections compared to men, due to the effects of
estrogen, birth control pills and the large number of
antibiotics prescriptions [1, 5, 49, 62].
Diagnosis Methods
Questionnaire
Candida albicans questionnaire is one of the most
useful screening methods to determine and understand
the likelihood of yeast-related illness. It is composed
by three sections: anamnesis, main symptoms and
other symptoms. The complete evaluation is made by
the sum of those sections, directing the treatment and
establishing hierarchy of intervention. Although Can-
dida questionnaire can be profitable, clinical evalua-
tion is one of the most important and credible methods
of diagnosis, including patient’s history and clinical
picture. Promptly, and according to the necessity,
laboratory examinations, such as stool cultures for C.
albicans and measurement of antibody levels or
antigens in the body, are very useful and accurate [5,
43, 57].
Comprehensive Digestive Stool Analysis (CDSA)
The stool sample culture exam is very common, but it
is inconclusive and provides little information in the
case of active infection. CDSA is an extremely useful
and effective method to determine the existence of
some digestive disturbances, functional and clinical
status of the GI tract, which can be one of the major
responsible factors of Candida overgrowth. It also
allows determination of the symptoms that are not
related with Candida overgrowth, but associated with
the intestinal bacteria overgrowth or presence of
inflammatory bowel disease [57, 59, 60, 62, 89].
Comprehensive digestive stool analysis is also
considered very important to maintain the optimal
functioning and ecology of the GI tract to improve
human health and wellness. This noninvasive method
of diagnosis can be considered as an integrated tool. It
provides advanced clinical insight and allows, care-
fully, an evaluation and examination not only of
digestion, absorption and intestinal capacity or func-
tion, but also of intestinal environment, gut immunol-
ogy and metabolism, microflora balance and colon risk
cancer. Therefore, in the last instance, it is helpful in
the diagnosis and monitorization of disease-specific
infections or conditions, but also determines the
etiology of diseases [57, 59, 60, 62, 89].
Laboratorial Techniques of Diagnostic
Laboratory techniques only confirm the patient’s his-
tory, physical examination and CDSA, only few addi-
tional data are provided, and it is rarely used. However,
there are situations in which the physician or the patients
intend to objectify which Candida species is the main
ethiogenic agent. In this case, microbiologic, molecular
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and biochemical assays could be used. For example, the
blood analysis can be useful, not only as a method of
determination/confirmation, as well as to monitoring
therapy. This test is based on measuring the level of
antibodies to Candida antigens. Other techniques, such
as urine test, used to measure yeast metabolites and
intestinal permeability, help to assess metabolic reasons
for candidiasis [57, 59, 60, 62].
Prevention
Considering the facts described above, and being C.
albicans a commensal microorganism and that is
present in all people, it is important to control the
number and magnitude of its population. As preven-
tion is the most effective treatment, much more than
the eradication of the yeast with antifungal agents—
synthetic or naturals, it is fundamental to address and
amend the predisposing factors. Therefore, maintain-
ing a good personal hygiene is essential. Moreover,
being woman more prone to this kind of infection, a
good vaginal and oral hygiene is essential, in order to
reduce the probability of candidiasis occurrence [5,
17, 42, 46, 49, 59, 60]. Some general guidelines for
personal hygiene are listed in Table 1.
Since deep infections have been increasing, mainly
in hospitals, the following aspects should be consid-
ered: probes and catheters should be regularly mon-
itored and removed, as soon as possible; and the
frequency, duration and amplitude of the quantities of
antibiotics should be kept to a minimum [3, 6, 9, 14,
49, 72, 90].
Not less important is to avoid certain risk factors,
such as diets rich in sugar and poor in vitamins and
minerals, or the use of antibiotics.
Alternative Treatment
Candida albicans is an opportunistic yeast that cause
infectious but, in some levels, lives and grows inside
most human bodies. In normal situations, Candida is
not harmful because our bodies are able to keep it
under control, mainly by immune cells and probiotic
bacteria. However, some factors previously discussed,
such as allergies, high-sugar diets, medications/drugs
and other factors that directly affect the normal
balance of intestinal environment, can kill the friendly
bacteria and stimulate the overgrowth of pathogenic
microorganisms [1, 68, 69, 84, 87, 88]. Therefore, the
best complementary treatment is to reduce and control
Candida levels. Several recommendations/interven-
tions are necessary according to each person. In most
of the cases, direct therapy for Candida species
destruction is advantageous, because it assists the
body on lowering Candida species to controllable
levels [49, 57, 59, 60]. However, depending on the
profile of the patient, other procedures (diet and
nutrition, enhancing immunity system, detoxification
and natural antiyeast agents, Fig. 1) are required and
will be discussed.
Therapeutic Considerations
Diet and Nutrition
As previously discussed, some dietary factors affect
and promote the overgrowth of C. albicans; there-
fore, following a special diet for the treatment of
candidiasis is crucial. The most important elements
are refined sugars, such as sucrose, fruit juice, honey
Table 1 Main general guidelines for personal hygiene [49, 59,
60, 62]
Procedures
Superficial
infections
Avoid contact with other body parts, as well
as with other persons
Maintain the skin clean and dry
During menstruation, compresses without
cosmetic products should be used
Vaginal
candidiasis
Avoid frequent use of vaginal douches and
intimate hygiene products (they alter the
normal vaginal pH, causing unbalance and
favoring the onset of infection)
Maintain external vaginal area completely
dry
Avoid prolonged use of bathing suit or damp
or wet underwear
The act of cleaning up should always be done
backward
Avoid sexual relations during antifungal
therapy
Personal
belongings
Bed linen, bathroom and personal clothing
should be washed with very hot water,
separated from the others at home and
disinfected after use
Avoid tight clothing and use cotton
underwear
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and other sweet foods, because C. albicans grows in
sugar environments. Foods with high content of fungi
or yeasts, such as alcoholic beverages, cheeses, dried
fruits, bread and fermented products, should be
avoided, as also milk and dairy products due to the
high content of lactose and, in some cases, trace
levels of antibiotics. Likewise, all the allergens
present in food should be eliminated, since allergies
weaken the immune system, promoting the growth of
pathogens. There are several reasons to restrict or
eliminate milk and other dairy products, not only for
the high levels of lactose that promote Candida
overgrowth, but also because it is one of the most
frequent food allergens, and the presence of trace
levels of antibiotics disrupts the GI bacterial flora
[42, 55, 57, 59, 60, 70, 87].
Food allergies could be assessed by some immu-
noanalytical methods, such as ELISA tests, which
determine both IgE- and IgG-mediated food allergies
and often help in the identification of allergies
[91–95].
Foods that can be eaten without problems and/or
constraints are vegetables, sources of proteins, such as
fish, meat and organic poultry, legumes and whole
grains. The latter consumption is dependent of each
individual tolerance. For fruits, although being the
majority alkaline, the recommendation is to eliminate
the consumption for a month of citrus and acidic fruits
(e.g., oranges, grapefruit, lemons, tomatoes, pineapple
and limes); afterward, the consumption can be made
twice a week. Apples, cranberries, cherries, pears and
other soft fruits can be daily consumed. Although the
existence of conflicting opinions, the consumption of
yogurt containing live probiotic cultures is recom-
mended in order to replace friendly bacteria. In some
cases, for vaginal candidiasis, a natural unprocessed
and unsweetened yogurt can be applied directly into
the vagina or a mixture of one small container of plain
yogurt with an equal amount of water can be used as a
douche, once or twice a day, until improvement is
observed. Alternatively, or complementary, it is also
possible to take supplemental acidophilus or bifidus,
or to open two capsules of acidophilus and add the
contents to a douche. It is also recommended to
consume daily oat bran and/or flaxseed, not only as a
source of fiber, being the latter also very effective due
to antifungal properties [49, 57, 59, 60].
Table 2 summarizes the most important dietary
aspects in fungal infections.
Enhancing Immune System
In most cases of chronic candidiasis, the immune
system is altered (mostly depressed) allowing a quick
growth of C. albicans. This explains why the patients
have repetitive cycles of infection that lead to increase
damages and further resistance weakening. Thereby, it
is very important to potentiate the immune function, in
order to protect the organism against foreign/oppor-
tunist agents. Additionally, in patients suffering from
AIDS or taking immunosuppressive drugs, the
immune system is affected, which favors the C.
albicans overgrowth. In both cases, the prevalence of
candidiasis is considerable, being the strength of the
immune function very important. In some cases, the
debility of the immune system is related to a decrease
in thymus function, represented by an impairment of
cell-mediated immunity [57, 59]. There are some
points that help to strength the immune function and
that eliminate, suppress or amend the causes of
depressed immune function. The major triggers of
impaired immunity and that lead to C. albicans
overgrowth are antibiotics, corticosteroids and other
drugs that suppress immune system, as also nutrients
Table 2 Dietary considerations in the treatment of candidiasis
[57, 59, 60, 62, 97]
Food
characteristics
Food products
To avoid Refined
carbohydrate
sources
Refined sugars (sucrose,
fructose, corn syrup), fruit
juice, honey, maple syrup
Fungi and/or
yeast sources
Alcoholic beverages, dried
fruits, cheeses, peanut
Lactose and
antibiotic
sources
Dairy products
Allergenic
foods
Dairy products, eggs,
chocolate, fried and
processed foods, wheat,
peanuts
To limit Carbohydrate
sources
Corn and potatoes
To
consume
Vitamin
sources
Vegetables, fruits (apples,
pears, cranberries, cherries,
blueberries and other soft
fruit)
Protein sources Fish, meat and biological
poultry
Fiber sources Whole grains, ground flaxseeds
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deficiency, food allergies and stress [1, 37, 40, 53, 69,
75, 80, 84].
Accordingly, restoring proper immune function is
one of the major objectives in the treatment of chronic
candidiasis; to reach this goal, some strategies could be
followed: stress management, diet restriction, nutri-
tional supplementation, glandular therapy, exercise
and the use of plant-based medicines. However, as the
clinical remission of candidiasis is directly dependent
on T-cells function, it is also crucial to improve thymus
gland function. To achieve this, it is necessary to
guarantee an adequate intake of antioxidants, through
nutritional supplementation, such as carotenes, vita-
mins A, C and E, zinc and selenium. Some plants could
be used to complement this intervention, namely
Echinacea angustifolia, Hydrastis canadensis and
Glycyrrhiza glabra [49, 57, 59, 62, 96].
Detoxification
The human body is continuously exposed to sub-
stances and toxic agents, which accumulates in the
body. Therefore, the body detoxification process is
continuous, being widely recognized that different
substances (e.g., heavy metals, pesticides, microbial
toxins and solvents) have considerable interferences in
the health and well-being of individuals. The liver is
an extremely important organ in the body, responsible
for vascular, metabolic and secretory functions. In
addition, it is also responsible for the detoxification of
all the chemical substances at which we are constantly
exposed (not only those ingested through diet and as a
result of the environment interaction, but also those
resulting from endogenous metabolic processes, such
as drugs and other cellular metabolisms). It has been
observed that the majority of subjects with C. albicans
overgrowth present some problems in liver detoxifi-
cation mechanisms. Moreover, the presence of multi-
ple chemical sensibilities and allergies is frequent in
patients with chronic candidiasis, which is a direct
indicator of problems in detoxification reactions. The
damage of liver is an underlying factor in chronic
candidiasis, as well as in chronic fatigue, because
when the liver is damaged by chemical toxins and
others, the immune function is severely compromised.
Thus, enhanced liver function is vital, not only before,
but also during and even after procedures that destroy
yeasts, in order to increase the likelihood of success in
candidiasis treatment [49, 57, 59, 60, 62].
Some procedures could help in the improvement of
detoxification process by liver (Table 3).
Natural Antiyeast Agents
Natural antiyeast agents with proven activity against
C. albicans can be used to treat the infection
concomitantly to other procedures. Nevertheless, to
be effective as primary therapy, predisposing factors
to chronic candidiasis, diet and lifestyle should also be
taken into account. The most studied compounds that
act as natural agents against C. albicans are caprylic
acid; berberine-containing plants; probiotics; grape-
fruit seed extract; garlic; tea tree oil; and enteric-
coated volatile oil preparations containing oregano,
thyme, peppermint and rosemary; propolis; ginger and
cinnamon. However, the occurrence of Herxheimer
reaction is very frequent when an effective antiyeast
therapy is used, due to the rapid elimination of the
microorganisms and subsequent absorption of large
amounts of yeast toxins, cell particles and antigens.
The mentioned reaction can be eliminated through
Table 3 Procedures to improve liver function and detoxifi-
cation [49, 57, 59, 60, 97]
Procedures
Improve liver
function
Consuming garlic, onions, chlorella,
spirulina, wheatgrass;
Diet based on fresh fruits and vegetables,
whole grains, legumes, nuts and seeds;
Avoiding alcohol and adopt others healthy
lifestyles;
Supplementation with a high-potency
multiple vitamin and minerals;
Regular exercise
Improve
detoxification
Diet based on high-fiber plant foods to
supplying a high amount of dietary fiber;
If necessary, prescribed additional fiber
formulas—3–5 g of soluble fiber at the
bedtime—composed by natural plant
fibers, derived from psyllium seed, kelp,
agar, pectin, guar and others that promote
a natural mechanism of bowel movement;
Using lipotropic formulasa such as choline,
betaine and methionine or cysteine,
silymarin to protect the liver
a The importance of lipotropic factors is related to increased
levels of two important liver substances: SAMs (S-
adenosylmethionine) and glutathione that are the major
lipotropic and detoxifying compounds in the liver, respectively
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supporting liver function, following dietary recom-
mendations and starting antiyeast medications in low
and gradually increasing doses [49, 57, 59, 60, 97].
Therapeutic Approach
In order to successively control the growth of C.
albicans and related infections (candidiasis), a thera-
peutic intervention is required.
After identification of the predisposing factors, it is
essential to develop a diet to control C. albicans
growing. The most commonly used substances and
phytotherapics in the complementary treatment of
candidiasis are presented in Table 4.
Besides the mentioned phytotherapics, there are
other plants with documented antifungal activity,
particularly against C. albicans, such as essential oils
from ginger (Zingiber officinale) [98–100], cassia
(Cinnamomum cassia) [98, 101] and others Cinnamo-
mum species [32, 102], chamomile (Matricaria cham-
omilla) [57, 103, 104], lemon balm (Melissa
officinalis) [32, 101, 105], thymus (Thymus vulgaris)
and rosemary (Rosmarinus officinalis) [101, 106–109].
Nevertheless, there are still several unknown com-
pounds from plants that could act synergistically,
among themselves and with other natural compounds,
against yeast infections [57, 59, 60, 97, 110].
Other aspects should also be considered, namely
rest and liquids intake mainly vegetable diluted juices,
soups and plant infusions. Moreover, it is necessary to
promote a positive mind and help patients to cope
stress. Alcohol, simple sugars, tobacco and cholesterol
should be avoided due to their capacity of stimulating
C. albicans overgrowth and impair the immune
function. The support to thymus gland function is also
provided by 500 mg of crude polypeptide fractions,
twice daily [57, 59, 60, 62, 96, 111].
The body ability to detoxify and eliminate some
substances is mostly dependent of healthy diet and
lifestyle. As previously mentioned, liver is the
responsible for the detoxification of all chemical
substances. Therefore, the optimization of liver
Table 4 Substances and phytochemicals commonly used in alternative treatment of candidiasis
Substance Dosage/description
High-potency complex of multivitamins and minerals formula Hypoallergenic formulas, free of yeasts
Zinc picolinate 45 mg/day
Selenium 200 lg/day
Caprylic acid Formula of slow liberation (1 g with meals)
Probiotics (intestinal flora) Products containing Lactobacillus
Fiber supplement Guar gum, pectin or psyllium seeds (1 teaspoon before bedtime)
Phytotherapics Dosage/description
Tabebuia impetiginosa (lapacho) 15–20 g of bark in 0.5 L boiling water for 5–15 min, 3–4 times/day;
Berberis vulgaris (barberry) The following doses, 3 times/day
Dried bark of the root (as tea): 1–2 g
Tincture (1:5): 4–6 mL (1–1 and  teaspoon)
Liquid extract (1:1): 0.5–2 mL (– teaspoon)
Powdered solid extract (4:1): 250–500 mg
Hydrastis Canadensis (goldenseal) The following doses, 3 times/day
Dried root (as tea): 1–2 g
Tincture (1:5): 4–6 mL (1–1 and  teaspoon)
Liquid extract (1:1): 0.5–2 mL (– teaspoon)
Powdered solid extract (4:1): 250–500 mg
Origanum vulgare (oregano) oil 300–500 mg by capsule or liquid form, 3 times/day, with meals to avoid
digestive unease
Allium sativum (garlic) Actual guidelines based on allin (10 mg) and allicin (4,000 lg), which is
equivalent to 4,000 mg of fresh garlic or 500–1,000 mg of aged garlic
Citrus paradise (grapefruit) seed extract 200 mg, 2–3 times/day
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function, promoting their protection and using lipo-
tropic factors, accelerates the elimination and fat
deposition in liver, and could offer significant benefits
[57, 59, 60, 97]. In some cases, the use of formulas
containing natural plant fibers derived from psyllium
seed, kelp, agar, pectin and plant gums is necessary to
help elimination of toxic substances and protect the
bowel wall from irritation. Moreover, these fiber
formulas promote natural bowel movements, and if
antiyeast therapies are employed, they guarantee that
dead yeast cells are excreted and not absorbed; 3–5 g
of soluble fiber at bedtime is required for the treatment
of candidiasis [57, 59, 60, 87, 88, 112, 113].
The repair of intestinal flora is another crucial
factor. Particularly, Lactobacilus acidophilus, Bifido-
bacterium bifidum, Lactobacillus bulgaricus and
Streptococcus thermophilus are very important, not
only as antifungals, antibacterials and antivirals, but
also in digestion and in production of vitamins and
other substances important to maintain gut and the all
body healthy. The recommendation is a product
containing 4–10 billion viable active organisms,
30 min after a meal. However, some foods, such as
yogurt and kefir, could also be a good source of
probiotics, but is necessary to take care, mainly due to
fact that the yogurt itself does not have the necessary
amount of bacteria, and in other hand, the presence of
sugar promotes the overgrowth of C. albicans and
other microorganisms. Therefore, the yogurt should
have the proper bacteria and should not be sweetened
[57, 59, 60, 87, 88, 112, 113].
Lastly, the use of nutritional supplements or herbs
seems to be the best option to help and control C.
albicans overgrowth, and to promote a healthy
bacterial flora. Antifungal drugs should be prescribed
only if necessary. In most cases, these therapeutic
interventions are effective to threat candidiasis,
including chronic candidiasis. However, if the patient
cannot achieve a significant improvement and/or
eradicate the infection, it is necessary to perform a
deeper evaluation [57, 59, 60, 62]. If the organism is
still present, after repeat stool cultures and measure
antigen levels, antibiotics could be prescribed, com-
bined with other recommendations [57, 59, 60].
Despite until now the majority of studies focused
essentially in the role of oils of plants, currently other
natural matrices preparations have been studied,
namely aqueous and alcoholic extracts. It is very
important to underline that the use of plants and other
botanical preparations are used, since ancient times,
by primitive societies, due to healing properties and
therapeutic and psychotherapeutic benefits. It is
important to address the fact that plants are widely
used to obtain a large variety of drugs, being used in
folk medicine for a long time [26–29, 32–35].
Concerning that plants represent an economic, easily
and which are accessible for all of people, they can be
used into a variety of diseases, constituting an
excellent source of biomolecules able to act like
natural antifungal agents and, at the same time, to
encourage the search for other alternative treatments.
They can be used both to complement a conventional
treatment with antifungal agents and singly like a
natural alternative treatment. In both situations, the
counseling and following of a growing control diet are
crucial to ensure successful of therapy.
Moreover, despite the increasing interest of several
studies toward the identification of several compounds
with therapeutic potential and their synergistic effect,
in combination with other compounds, many proper-
ties of plants remain unknown, as well as their main
compounds. Thus, not only it is necessary to deepen
the study of other preparations of known plants but
also to investigate other therapeutic effects provided
by plants and the major responsible compounds.
Concluding Remarks
All people are exposed to a variety of candidiasis
predisposing factors, and some of them are impossible
to avoid. Candidiasis can affect different parts of the
body (nails, GI tract and vagina, among others) being
characterized by several symptoms, which often-
difficult diagnosis; additionally, the individual char-
acteristics alter the manifestation of signals and
symptoms. As this infection is very uncomfortable
and, in some cases, offers a considerable health risk,
the major and most important aspect is prevention.
Therefore, there are several aspects to consider and
include in the daily routine, which at first might seem
insignificant, but that could provide a strength
protection.
To combat the infection, different procedures are
necessary according to the pathologic conditions of
the patient; if all daily care is considered, the
probability of the infection occurrence will be con-
siderably reduced. However, in face of an infection, a
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123
rapid intervention is necessary, and for this, other
alternatives to antifungals and antimicrobials are
necessary.
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